[Clinical and physiopathological findings in lichen sclerosus et atrophicus].
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear; D001323:Autoantibodies / Q000032:analysis*; D001341:Autonomic Nervous System / Q000503:physiopathology*; D002907:Chronaxy; D003881:Dermatomycoses / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011736:Pyridoxine / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000175:diagnosis; D012871:Skin Diseases; D014364:Tryptophan / Q000008:administration & dosage / Q000378:metabolism; D014977:Xanthurenates / Q000652:urine
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D014977:Xanthurenates; D014364:Tryptophan; D011736:Pyridoxine
Klinische und pathophysiologische Befunde bei Lichen sclerosus et atrophicus.